(-0.06%) 5 184.51 points
(0.35%) 39 021 points
(-0.24%) 16 293 points
(0.87%) $79.06
(-1.18%) $2.18
(-0.15%) $2 320.60
(0.23%) $27.61
(-0.23%) $986.15
(0.10%) $0.930
(0.03%) $10.90
(0.10%) $0.800
(0.20%) $91.63
-2.72% $ 41.06
@ $36.11
Emitido: 14 feb 2024 @ 13:49
Retorno: 13.72%
Señal anterior: feb 13 - 12:40
Señal anterior:
Retorno: 0.46 %
Live Chart Being Loaded With Signals
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases...
Stats | |
---|---|
Volumen de hoy | 187 525 |
Volumen promedio | 939 698 |
Capitalización de mercado | 2.71B |
EPS | $0 ( 2024-05-02 ) |
Próxima fecha de ganancias | ( $-0.690 ) 2024-06-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -14.36 |
ATR14 | $0.0480 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-13 | Jimenez Freddy A. | Buy | 20 000 | Common Stock |
2024-02-13 | Jimenez Freddy A. | Buy | 4 166 | Common Stock |
2024-02-13 | Jimenez Freddy A. | Sell | 4 166 | Incentive Stock Option (Right to Buy) |
2024-02-13 | Jimenez Freddy A. | Sell | 20 000 | Incentive Stock Option (Right to Buy) |
2024-01-02 | Martin Samuel Bates | Buy | 10 750 | Common Stock |
INSIDER POWER |
---|
75.37 |
Last 97 transactions |
Buy: 2 900 849 | Sell: 507 801 |
Volumen Correlación
Celldex Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
NSTS | 0.918 |
BOKF | 0.917 |
FNWD | 0.917 |
GCBC | 0.916 |
NECB | 0.913 |
UMBF | 0.913 |
MSBI | 0.91 |
HMNF | 0.909 |
AHPI | 0.907 |
FSBC | 0.906 |
10 Correlaciones Más Negativas | |
---|---|
CHMA | -0.906 |
VTIP | -0.906 |
DSPG | -0.895 |
SUMO | -0.893 |
SOPH | -0.887 |
SMED | -0.882 |
OSMT | -0.878 |
NVCN | -0.876 |
MNTV | -0.876 |
DVCR | -0.872 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Celldex Therapeutics Inc Correlación - Moneda/Commodity
Celldex Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $6.88M |
Beneficio Bruto: | $3.88M (56.30 %) |
EPS: | $-2.92 |
FY | 2023 |
Ingresos: | $6.88M |
Beneficio Bruto: | $3.88M (56.30 %) |
EPS: | $-2.92 |
FY | 2022 |
Ingresos: | $2.36M |
Beneficio Bruto: | $957 000 (40.60 %) |
EPS: | $-2.62 |
FY | 2021 |
Ingresos: | $4.65M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.640 |
Financial Reports:
No articles found.
Celldex Therapeutics Inc
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico